Terkel Hansen - Concepedia

Concepedia

Author

Terkel Hansen

UiT The Arctic University of Norway ORCID

Also Known As

Hansen, T.M., Hansen, Terkel, T Hansen, T. Hansen, T. Matthew Hansen, T.Matthew Hansen, Terkel Hansen, terkel hansen

73

Publications

1.9K

Citations

25

H-Index

59

Concepts

All Affiliations

UiT The Arctic University of Norway AbbVie (United States)University Hospital of North Norway Abbott Fund University of Minnesota

TH

About

Terkel Hansen is an author at UiT The Arctic University of Norway specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	389
2	Biochemistry	9	9	275
3	Natural Sciences	7	7	219
4	Engineering	5	5	286
5	Biomedical Engineering	2	2	53

Terkel Hansen

×

38

Publications

1.9K

Citations

25

H-Index

	Year	Citations
Starvation induces rapid degradation of selective autophagy receptors by endosomal microautophagy Jakob Mejlvang, Hallvard Lauritz Olsvik, Steingrim Svenning, The Journal of Cell Biology	2018	269
Highly chemoselective oxidation of 1,5-diols to δ-lactones with TEMPO/BAIB Terkel Hansen, Gordon J. Florence, Priscilla Lugo‐Mas, Tetrahedron Letters EngineeringChemoselective OxidationOrganic ChemistryCatalysisChemistry	2003	177
Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X<sub>L</sub> Inhibitor Le Wang, George Doherty, Andrew S. Judd, ACS Medicinal Chemistry Letters	2020	127
Lipidomics in Ulcerative Colitis Reveal Alteration in Mucosal Lipid Composition Associated With the Disease State Joseph Diab, Terkel Hansen, Rasmus Goll, Inflammatory Bowel Diseases	2019	95
Antimicrobial Activity of Small β-Peptidomimetics Based on the Pharmacophore Model of Short Cationic Antimicrobial Peptides Terkel Hansen, Tore Alst, Martina Havelková, Journal of Medicinal Chemistry	2009	83
Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases Michael R. Michaelides, Arthur F. Kluge, Michael A. Patane, ACS Medicinal Chemistry Letters	2017	72
Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors Le Wang, John K. Pratt, Todd Soltwedel, Journal of Medicinal Chemistry	2017	64
Total Synthesis of Phorboxazole A via <i>de Novo</i> Oxazole Formation: Strategy and Component Assembly Bo Wang, Terkel Hansen, Ting Wang, Journal of the American Chemical Society	2010	56
Synthesis and Structure−Activity Relationships of <i>N</i>-{3-[2-(4-Alkoxyphenoxy)thiazol-5-yl]-1- methylprop-2-ynyl}carboxy Derivatives as Selective Acetyl-CoA Carboxylase 2 Inhibitors Yu Gu, Moshe Weitzberg, Richard F. Clark, Journal of Medicinal Chemistry Selective Acc2 InhibitorsOrganic ChemistryPharmacotherapyAcc2 Selective InhibitorsPharmaceutical Chemistry	2006	55
Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients Junichiro Yuda, Christine Will, Darren C. Phillips, Communications Medicine	2023	52

Page 1